- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05792982
Serum Fibroblast Growth Factor-21 Levels During Prolonged Fasting
March 29, 2023 updated by: Zeynep Goktas, Hacettepe University
Fluctuations of Serum Fibroblast Growth Factor-21 Levels During Prolonged Fasting in Male Adults
The investigators hypothesized that serum FGF21 levels would increase with prolongation of the fasting period.
The investigators also hypothesized that food intake and body composition would change.
The study was conducted with 12 healthy male adults.
A questionnaire was administered at the beginning of the study.
Anthropometric measurements, dietary intake and physical activities were recorded and blood samples were taken before, during and after Ramadan.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The aim of this study was to determine the effects of hunger on serum Fibroblast Growth Factor 21 (FGF21) levels, nutritional status and anthropometric measurements of adult males during fasting.
FGF21 is a significant protein in the process of adaption to fasting due to its effects on liver, adipose tissue, and brain.
A total of 12 healthy individuals with normal body mass index, between the ages of 18 to 35 participated to this cross-sectional study.
All participants provided written informed consent.
Sample size determined with power analysis.
A questionnaire was administered in order to determine individuals' general characteristics, nutrition habits, and smoking and alcohol habits.
Anthropometric measurements, 24 hours dietary recall and physical activities were recorded and blood samples were taken four times in following periods; before Ramadan, first week of Ramadan, third week of Ramadan and two weeks after Ramadan.
Serum FGF21 levels were determined by ELISA (Enzyme-Linked Immunosorbent Assay).
Mean energy and nutrient intake were calculated by BEBIS (Nutrition Information System) and results were compared with Recommended Dietary Allowances (RDA).
Paired samples t-test and Wilcoxon-signed rank test were used to explore differences.
The study was approved by Hacettepe University Non-Interventional Clinical Research Ethics Board.
Study Type
Observational
Enrollment (Actual)
12
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Ankara, Turkey, 06100
- Hacettepe University Nutrition and Dietetics Department
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
19 years to 35 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Male
Sampling Method
Probability Sample
Study Population
Individuals were recruited through social media announcements.
Individuals residing in Ankara, where Hacettepe University is located, were recruited.
Description
Inclusion Criteria:
- Being healthy male,
- Being between the ages of 19-35,
- Fasting regularly during Ramadan.
Exclusion Criteria:
- Being females,
- Being younger than 19 years and older than 35 years of age,
- Having a BMI less than 18.5 kg/m2 and greater than 24.9 kg/m2,
- Having any chronic metabolic disease,
- Individuals who not fast regularly during Ramadan.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Fasting Adult Males
A questionnaire was administered in order to determine individuals' general characteristics, nutrition habits, and smoking and alcohol habits.
Anthropometric measurements, 24 hours dietary recall and physical activities were recorded and blood samples were taken four times in following periods; before Ramadan, first week of Ramadan, third week of Ramadan and two weeks after Ramadan.
|
This study aims to determine the effects of fasting on serum FGF21 levels.
For this reason, male adults who fasted during the Ramadan were included in the study.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
FGF-21 levels
Time Frame: 3 months
|
Blood samples were collected and serum FGF21 levels were determined by ELISA method
|
3 months
|
|
Body weight
Time Frame: 3 months
|
Body weight was measured using a scale with 100g sensitivity.
|
3 months
|
|
Body fat ratio
Time Frame: 3 months
|
Body fat ratio was measured by a bioelectrical impedance analysis device.
|
3 months
|
|
Body muscle composition
Time Frame: 3 months
|
Body fat composition was measured by a bioelectrical impedance analysis device.
|
3 months
|
|
Dietary Intake
Time Frame: 3 months
|
24-hour dietary recall questionnaires were administered by researchers.
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2017
Primary Completion (Actual)
July 30, 2017
Study Completion (Actual)
January 30, 2018
Study Registration Dates
First Submitted
March 17, 2023
First Submitted That Met QC Criteria
March 29, 2023
First Posted (Actual)
March 31, 2023
Study Record Updates
Last Update Posted (Actual)
March 31, 2023
Last Update Submitted That Met QC Criteria
March 29, 2023
Last Verified
March 1, 2023
More Information
Terms related to this study
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fasting
-
University of BariCompleted
-
University of GuelphCompletedRamadan FastingCanada
-
University of ChileAgencia Nacional de Investigación y DesarrolloCompletedIntermittent Fasting in Shift-workChile
-
Charite University, Berlin, GermanySoftware AG Stiftung; Eden Stiftung; Reformhaus StiftungEnrolling by invitation
-
University of California, San DiegoRecruitingDepression - Major Depressive DisorderUnited States
-
Sanliurfa Education and Research HospitalEnrolling by invitation
-
USDA, Western Human Nutrition Research CenterUniversity of California, DavisCompletedCardiovascular Risk Factor | Athletic Performance | Fasting | Resting Energy Expenditure | Intermittent FastingUnited States
-
King Faisal UniversitySaudi Food and Drug AuthorityRecruitingDietary Intervention | Glycemic Response; Satiety | Postprandial Glucose | Fasting, Time RestrictedSaudi Arabia
-
Desitin Arzneimittel GmbHBioPharma Services, IncCompleted
-
Beth Israel Deaconess Medical CenterCompleted
Clinical Trials on 12 hour fasting for 29 days
-
Pacific Northwest University of Health SciencesCompletedLong COVID | Long Covid19United States
-
Wageningen UniversityCompletedEating BehaviorNetherlands
-
Yonsei UniversityUnknownAtrial FibrillationKorea, Republic of
-
Intermountain Health Care, Inc.Intermountain Research and Medical FoundationCompleted
-
Harvard School of Dental MedicineUnknownAdjunctive Usage of Vibrational Therapy | Dental Monitoring Accuracy
-
Bozyaka Training and Research HospitalCompletedIschemia | Intraoperative Complications | FastingTurkey
-
University of AarhusCompletedFasting | Metabolism | Nutrition SupportDenmark
-
Hartford HospitalOptimer Pharmaceuticals LLCCompletedClostridium Difficile InfectionUnited States
-
The University of Texas Health Science Center,...RecruitingAcute Kidney InjuryUnited States
-
The University of Texas Health Science Center,...The University of Texas Health Science Center at San AntonioRecruiting